Emergent BioSolutions EBS
NYSE EBS
$4.82 -0.07 (-1.43%)
At close: Aug 20, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Debt Ratio (2010 - 2026)

Emergent BioSolutions (EBS) posted quarterly Debt Ratio of 0.43 for Q1 2026, down 6.94% year-over-year from 0.47 in Q1 2025, and little changed quarter-over-quarter from 0.43 in Q4 2025.

Emergent BioSolutions (EBS) Debt Ratio (2010 - 2026) Analysis & Trends

Emergent BioSolutions' Debt Ratio history runs 17 years deep, the most recent figure standing at 0.43 for Q1 2026.

  • In Q1 2026, Debt Ratio fell 6.94% year-over-year to 0.43; the TTM figure through Mar 2026 stood at 0.43 (down 6.94% YoY), while the FY2025 annual figure was 0.43, down 9.15% from the prior year.
  • Debt Ratio for Q1 2026 stood at 0.43, roughly flat from 0.43 in the prior quarter.
  • The five-year high for Debt Ratio was 0.57 in Q2 2024, with the low at 0.14 in Q4 2022.
  • The 5-year median for Debt Ratio is 0.43 (2025), against an average of 0.38.
  • The sharpest annual moves came in 2022 and 2024: Debt Ratio plunged 50.69% in 2022, then jumped 232.14% in 2024.
  • Emergent BioSolutions' Debt Ratio stood at 0.14 in 2022, then surged by 72.89% to 0.24 in 2023, then jumped by 95.01% to 0.48 in 2024, then decreased by 9.15% to 0.43 in 2025, then rose by 0.13% to 0.43 in 2026.
  • Business Quant data shows EBS's Debt Ratio at 0.43 in Q1 2026, 0.43 in Q4 2025, and 0.47 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -0.13
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 0.42
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 0.60
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 0.32
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 0.38
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 0.29
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 0.12
10 Emergent BioSolutions 251.81 Mn 110.91 Mn 137.20 Mn 0.53

Historic Data

Download Data
DateValue
Jun 30, 2026 0.53
Mar 31, 2026 0.43
Dec 31, 2025 0.43
Sep 30, 2025 0.47
Jun 30, 2025 0.49
Mar 31, 2025 0.47
Dec 31, 2024 0.48
Sep 30, 2024 0.47
Jun 30, 2024 0.57
Mar 31, 2024 0.50
Dec 31, 2023 0.24
Sep 30, 2023 0.24
Jun 30, 2023 0.42
Mar 31, 2023 0.15
Dec 31, 2022 0.14
Sep 30, 2022 0.36
Jun 30, 2022 0.30
Mar 31, 2022 0.30
Dec 31, 2021 0.29
Sep 30, 2021 0.30